MECHANISM OF LEUKEMOGENESIS BY DUAL FUNCTIONS OF AML1/EVI-1 CHIMERIC PROTEIN IN T(3-21) LEUKEMIAS

被引：0
|
作者：
TANAKA, T
MITANI, K
KUROKAWA, M
OGAWA, S
TANAKA, K
NISHIDA, J
YAZAKI, Y
SHIBATA, Y
HIRAI, H
机构：
[1] UNIV TOKYO,FAC MED,DEPT TRANSFUS & IMMUNOHEMATOL,TOKYO 113,JAPAN
[2] UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO 113,JAPAN
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A230 / A230
页数：1
相关论文
共 50 条
  • [1] DUAL FUNCTIONS OF THE AML1/EVI-1 CHIMERIC PROTEIN IN THE MECHANISM OF LEUKEMOGENESIS IN T(3-21) LEUKEMIAS
    TANAKA, T
    MITANI, K
    KUROKAWA, M
    OGAWA, S
    TANAKA, K
    NISHIDA, J
    YAZAKI, Y
    SHIBATA, Y
    HIRAI, H
    MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (05) : 2383 - 2392
  • [2] Molecular mechanisms of leukemogenesis by AML1/EVI-1
    Kinuko Mitani
    Oncogene, 2004, 23 : 4263 - 4269
  • [3] THE AML1 EVI-1 FUSION PROTEIN IN THE T(3-21) TRANSLOCATION EXHIBITS TRANSFORMING ACTIVITY ON RAT1 FIBROBLASTS WITH DEPENDENCE ON THE EVI-1 SEQUENCE
    KUROKAWA, M
    OGAWA, S
    TANAKA, T
    MITANI, K
    YAZAKI, Y
    WITTE, ON
    HIRAI, H
    ONCOGENE, 1995, 11 (05) : 833 - 840
  • [4] Molecular mechanisms of leukemogenesis by AML1/EVI-1
    Mitani, K
    ONCOGENE, 2004, 23 (24) : 4263 - 4269
  • [5] The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP
    Koji Izutsu
    Mineo Kurokawa
    Yoichi Imai
    Motoshi Ichikawa
    Takashi Asai
    Kazuhiro Maki
    Kinuko Mitani
    Hisamaru Hirai
    Oncogene, 2002, 21 : 2695 - 2703
  • [6] The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP
    Izutsu, K
    Kurokawa, M
    Imai, Y
    Ichikawa, M
    Asai, T
    Maki, K
    Mitani, K
    Hirai, H
    ONCOGENE, 2002, 21 (17) : 2695 - 2703
  • [7] The t(3;21) fusion product, AML1/Evi-1, blocks AML1-induced transactivation by recruiting CtBP.
    Izutsu, K
    Kurokawa, M
    Imai, Y
    Mitani, K
    Hirai, H
    BLOOD, 2001, 98 (11) : 833A - 834A
  • [8] ONCOGENIC POTENTIALS OF THE AML1 EVI-1 FUSION PROTEIN-DERIVED FROM THE T(3-21)(Q26-Q22) TRANSLOCATION IN BLASTIC CRISIS OF CHRONIC MYELOCYTIC-LEUKEMIA
    MITANI, K
    KUROKAWA, M
    OGAWA, S
    TANAKA, T
    YAZAKI, Y
    HIRAI, H
    BLOOD, 1994, 84 (10) : A229 - A229
  • [9] GROWTH-INHIBITION OF LEUKEMIC-CELLS CARRYING THE T(3-21) BY THE AML1/EVI-1-SPECIFIC ANTISENSE OLIGONUCLEOTIDE
    MITANI, K
    OGAWA, S
    TANAKA, T
    KUROKAWA, M
    YAZAKI, Y
    HIRAI, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (03) : 711 - 714
  • [10] AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1
    M Takeshita
    M Ichikawa
    E Nitta
    S Goyama
    T Asai
    S Ogawa
    S Chiba
    M Kurokawa
    Leukemia, 2008, 22 : 1241 - 1249
12345